DK3095856T3 - Sammensætninger med trombocytindhold - Google Patents

Sammensætninger med trombocytindhold Download PDF

Info

Publication number
DK3095856T3
DK3095856T3 DK16170752.6T DK16170752T DK3095856T3 DK 3095856 T3 DK3095856 T3 DK 3095856T3 DK 16170752 T DK16170752 T DK 16170752T DK 3095856 T3 DK3095856 T3 DK 3095856T3
Authority
DK
Denmark
Prior art keywords
trombocytic
compositions
contents
trombocytic contents
Prior art date
Application number
DK16170752.6T
Other languages
English (en)
Inventor
Allan B Dietz
Greg W Butler
Michael P Gustafson
Original Assignee
Mayo Found Medical Education & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42040115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3095856(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mayo Found Medical Education & Res filed Critical Mayo Found Medical Education & Res
Application granted granted Critical
Publication of DK3095856T3 publication Critical patent/DK3095856T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16170752.6T 2008-09-16 2009-09-16 Sammensætninger med trombocytindhold DK3095856T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9749008P 2008-09-16 2008-09-16
EP09815127.7A EP2334785B2 (en) 2008-09-16 2009-09-16 Compositions containing platelet contents

Publications (1)

Publication Number Publication Date
DK3095856T3 true DK3095856T3 (da) 2019-10-21

Family

ID=42040115

Family Applications (3)

Application Number Title Priority Date Filing Date
DK19181191.8T DK3584310T3 (da) 2008-09-16 2009-09-16 Sammensætninger med blodpladeindhold
DK09815127T DK2334785T4 (da) 2008-09-16 2009-09-16 Sammensætninger med trombocytindhold
DK16170752.6T DK3095856T3 (da) 2008-09-16 2009-09-16 Sammensætninger med trombocytindhold

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK19181191.8T DK3584310T3 (da) 2008-09-16 2009-09-16 Sammensætninger med blodpladeindhold
DK09815127T DK2334785T4 (da) 2008-09-16 2009-09-16 Sammensætninger med trombocytindhold

Country Status (7)

Country Link
US (4) US20110171731A1 (da)
EP (3) EP3584310B1 (da)
DK (3) DK3584310T3 (da)
ES (2) ES2588383T5 (da)
FI (1) FI3584310T3 (da)
HK (1) HK1231508A1 (da)
WO (1) WO2010033605A2 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121979A1 (en) * 2003-12-29 2013-05-16 Allan Mishra Method of treating cancer using platelet compositions
DK3584310T3 (da) 2008-09-16 2024-07-08 Mayo Found Medical Education & Res Sammensætninger med blodpladeindhold
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
US20120231542A1 (en) * 2011-03-11 2012-09-13 General Biotechnology, Llc Biologically Active Human Umbilical Cord Blood Cell Extract Compounds and Methods
AU2012275562B2 (en) * 2011-06-27 2016-10-20 Children's Healthcare Of Atlanta, Inc. Compositions, uses, and preparation of platelet lysates
SG10201605518XA (en) 2011-07-06 2016-08-30 Cell Therapy Ltd Progenitor Cells Of Mesodermal Lineage
MY173148A (en) 2011-11-23 2019-12-31 Cell Therapy Ltd Platelet lysate gel
TW201335372A (zh) * 2011-11-30 2013-09-01 Nat Cancer Ct 誘導惡性幹細胞
US9682104B2 (en) * 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
EP3038551A4 (en) * 2013-08-27 2017-03-08 Mayo Foundation for Medical Education and Research Cross-linked platelet material
BR112016004510A2 (pt) 2013-08-27 2017-09-12 Cook General Biotechnology Llc composições bioativas deriváveis de concentrados de plaquetas e métodos para preparar e usar as mesmas
EP4328299A3 (en) * 2014-05-16 2024-05-29 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
WO2016014854A1 (en) 2014-07-23 2016-01-28 Cerus Corporation Methods for preparing platelet products
EP3267965A4 (en) * 2015-03-11 2018-11-14 Atta Behfar Exosome delivery technology
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
JP2018517771A (ja) 2015-05-29 2018-07-05 ジャディ セル エルエルシー 粒状の凍結乾燥血小板溶解物組成物
RU2648162C2 (ru) * 2016-04-21 2018-03-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В.Ломоносова" (МГУ) Способ получения ростовой добавки на основе лизата тромбоцитов из тромбоцитарной массы доноров к среде для наращивания клеточной массы стволовых, прогениторных, дифференцированных и опухолевых клеток
FR3077823B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
FR3077824B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
CN116926001A (zh) * 2022-04-06 2023-10-24 上海我武干细胞科技有限公司 血清替代物及其制备方法与应用
CN114836381B (zh) * 2022-05-22 2023-03-28 北京赛尔再生医学生物科技有限公司 诱导间充质干细胞定向分化为神经细胞的方法及其培养基
CN115125191B (zh) * 2022-08-22 2023-10-13 浙江绿蔻生物技术有限公司 成纤维细胞转化培养基及其应用、成纤维细胞的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185160A (en) * 1984-06-21 1993-02-09 Prp, Inc. Platelet membrane microvesicles
SE8801537D0 (sv) * 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
US5756686A (en) * 1988-12-20 1998-05-26 Ludwig Institute For Cancer Research Peptides derived from endothelial cell growth factor
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
WO1995015763A1 (en) 1993-12-08 1995-06-15 Universite De Montreal Process for the preparation of serum and platelet growth factors extract
US5834418A (en) * 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
US20020164322A1 (en) * 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
AU2002226426A1 (en) * 2002-01-09 2003-07-24 Alberto Gorrochategui Barrueta Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
US20070122906A1 (en) * 2003-12-29 2007-05-31 Allan Mishra Method of culturing cells
WO2005065242A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Method of treating cancer using platelet releasate
US20060014266A1 (en) * 2004-06-10 2006-01-19 Cytokinetics, Inc. Purification of Arp2/3 complex and compositions containing purified Arp2/3 complex
US7335508B2 (en) * 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
SE528214C2 (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
EP2069479A1 (en) * 2006-09-18 2009-06-17 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
WO2008110570A1 (en) 2007-03-13 2008-09-18 Medizinische Universität Graz Method to study proliferation of endothelial progenitor cells and the potential influence of compounds on their proliferation behaviour
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
EP2100954A1 (en) * 2008-03-10 2009-09-16 Assistance Publique - Hopitaux de Paris Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
EP2620493B1 (en) * 2008-05-28 2019-03-27 Ramot at Tel Aviv University Ltd. Mesenchymal stem cells for the treatment of CNS diseases
IT1392897B1 (it) * 2008-07-18 2012-04-02 Fond Ircss Ca' Granda - Ospedale Maggiore Policlinico Frazione piastrinica derivante da sangue placentare
US20110293576A1 (en) 2008-08-04 2011-12-01 Allocure Inc. Mesenchymal stromal cell populations and methods of isolating and using same
DK3584310T3 (da) 2008-09-16 2024-07-08 Mayo Found Medical Education & Res Sammensætninger med blodpladeindhold
WO2011053860A2 (en) * 2009-10-30 2011-05-05 Allocure, Inc. Mesenchymal stromal cell populations and methods of using same
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
MY173148A (en) 2011-11-23 2019-12-31 Cell Therapy Ltd Platelet lysate gel
US9682104B2 (en) 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
EP4328299A3 (en) 2014-05-16 2024-05-29 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
BR112017018885A2 (pt) * 2015-03-04 2018-04-17 Mesoblast Int Sarl método de cultura celular para células-tronco mesenquimais
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire

Also Published As

Publication number Publication date
DK2334785T4 (da) 2019-11-18
EP3095856A1 (en) 2016-11-23
ES2588383T3 (es) 2016-11-02
US10925901B2 (en) 2021-02-23
EP2334785A4 (en) 2013-01-16
WO2010033605A3 (en) 2010-07-22
DK3584310T3 (da) 2024-07-08
ES2588383T5 (es) 2020-04-22
WO2010033605A2 (en) 2010-03-25
EP3095856B1 (en) 2019-08-14
EP2334785B2 (en) 2019-08-14
US20110171731A1 (en) 2011-07-14
US20190209617A1 (en) 2019-07-11
US20160082047A1 (en) 2016-03-24
US10166258B2 (en) 2019-01-01
HK1231508A1 (zh) 2017-12-22
ES2755551T3 (es) 2020-06-05
FI3584310T3 (fi) 2024-07-02
EP2334785A2 (en) 2011-06-22
US20210154234A1 (en) 2021-05-27
EP2334785B1 (en) 2016-05-25
EP3584310B1 (en) 2024-04-17
EP3584310A1 (en) 2019-12-25
DK2334785T3 (da) 2016-08-22

Similar Documents

Publication Publication Date Title
DK2334785T4 (da) Sammensætninger med trombocytindhold
SMT201600307B (it) Composizione liposomiale
DK2373293T3 (da) Sammensætninger med reduceret dimerdannelse
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
DK2634231T3 (da) Sammensætninger
DE602008002756D1 (de) Bauzusammensetzung
BRPI0910515A2 (pt) composição líquida
BRPI1013588A2 (pt) composição
BRPI0914745A2 (pt) composição nutricional
BRPI0917231A2 (pt) composição
BRPI1015474A2 (pt) composição
BRPI0905874A2 (pt) Composição fotoprotetora
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0813775A2 (pt) Composição
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
DK2323515T3 (da) Beholderholder med fastgørelsesmidler
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
DK2285413T3 (da) Farmaceutisk sammensætning
DK2346679T3 (da) Forbedrede kompositmaterialer
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0811002A2 (pt) Composição biofertilizante
BRPI1005290A2 (pt) composição
BRPI0820960A2 (pt) composição